151 related articles for article (PubMed ID: 19070300)
1. Therapeutic vignette: old and new drugs in mixed connective tissue disease.
Rozenbaum M; Slobodin G; Boulman N; Feld J; Avshovich N; Ben-Arieh Y; Rosner I
Isr Med Assoc J; 2008 Nov; 10(11):831-2. PubMed ID: 19070300
[No Abstract] [Full Text] [Related]
2. Tumor necrosis factor-alpha antagonists induce lupus-like syndrome in patients with scleroderma overlap/mixed connective tissue disease.
Christopher-Stine L; Wigley F
J Rheumatol; 2003 Dec; 30(12):2725-7. PubMed ID: 14719225
[No Abstract] [Full Text] [Related]
3. Diffuse large B-cell lymphoma in a patient with rheumatoid arthritis treated with infliximab and methotrexate.
Nakashima C; Tanioka M; Takahashi K; Miyachi Y
Clin Exp Dermatol; 2008 Jul; 33(4):437-9. PubMed ID: 18485021
[TBL] [Abstract][Full Text] [Related]
4. Use of infliximab in the treatment of psoriasis.
Lee MR; Cooper AJ
Australas J Dermatol; 2004 Aug; 45(3):193-5. PubMed ID: 15250904
[No Abstract] [Full Text] [Related]
5. Mixed connective tissue disease with protein-losing enteropathy: discussion of the treatment strategy.
Chao CT; Lai CY; Chang PL; Wu HS; Wu VC; Wang WJ
J Clin Rheumatol; 2011 Aug; 17(5):286-7. PubMed ID: 21778905
[No Abstract] [Full Text] [Related]
6. Therapy for severe necrotizing vasculitis with infliximab.
Mang R; Ruzicka T; Stege H
J Am Acad Dermatol; 2004 Aug; 51(2):321-2. PubMed ID: 15280860
[No Abstract] [Full Text] [Related]
7. Abatacept: new drug. Rheumatoid arthritis: after failure of TNF alpha antagonists and rituximab.
Prescrire Int; 2008 Dec; 17(98):232. PubMed ID: 19422143
[No Abstract] [Full Text] [Related]
8. Disseminated cryptococcal infection and anti-tumor necrosis factor-alpha treatment for refractory sarcoidosis: an expected association?
Arnaud L; Sene D; Costedoat-Chalumeau N; Cacoub P; Chapelon-Abric C; Piette JC
J Rheumatol; 2009 Feb; 36(2):462-3. PubMed ID: 19208587
[No Abstract] [Full Text] [Related]
9. Serpiginous choroiditis.
Cordero-Coma M; Benito MF; Hernández AM; Antolín SC; Ruíz JM
Ophthalmology; 2008 Sep; 115(9):1633, 1633.e1-2. PubMed ID: 18762076
[No Abstract] [Full Text] [Related]
10. Successful treatment of rheumatoid vasculitis-associated skin ulcer with a TNF-α antagonist.
Ashida A; Murata H; Mikoshiba Y; Ohashi A; Kobayashi A; Koga H; Uhara H; Okuyama R
Int J Dermatol; 2014 Feb; 53(2):e154-6. PubMed ID: 23557520
[No Abstract] [Full Text] [Related]
11. [Mixed connective tissue disease: progress in diagnosis and treatment. III. Treatment. 2. Timing for the start of the therapy with adrenocorticosteroids and immunosuppressive agents and methods of their administration].
Tanaka H
Nihon Naika Gakkai Zasshi; 1996 Aug; 85(8):1233-6. PubMed ID: 8965020
[No Abstract] [Full Text] [Related]
12. Trigeminal neuralgia as the first manifestation of mixed connective tissue disorder.
Hojaili B; Barland P
J Clin Rheumatol; 2006 Jun; 12(3):145-7. PubMed ID: 16755246
[TBL] [Abstract][Full Text] [Related]
13. Disseminated Mycobacterium marinum infection in a patient with rheumatoid arthritis receiving infliximab therapy.
Danko JR; Gilliland WR; Miller RS; Decker CF
Scand J Infect Dis; 2009; 41(4):252-5. PubMed ID: 19266397
[TBL] [Abstract][Full Text] [Related]
14. Hemobilia due to vasculitis of the gall bladder in a patient with mixed connective tissue disease.
Kuipers EJ; van Leeuwen MA; Nikkels PG; Jager J; van Rijswijk MH
J Rheumatol; 1991 Apr; 18(4):617-8. PubMed ID: 2066956
[TBL] [Abstract][Full Text] [Related]
15. A case of Raynaud's phenomenon in mixed connective tissue disease responding to rituximab therapy.
Haroon M; O'Gradaigh D; Foley-Nolan D
Rheumatology (Oxford); 2007 Apr; 46(4):718-9. PubMed ID: 17289791
[No Abstract] [Full Text] [Related]
16. Recalcitrant leg ulcer due to mixed connective tissue disease.
Rozin AP; Braun-Moscovici Y; Bergman R; Balbir-Gurman A
Neth J Med; 2006 Mar; 64(3):91-4. PubMed ID: 16547364
[TBL] [Abstract][Full Text] [Related]
17. [A case of cutaneous tuberculosis associated with steroid therapy for mixed connective tissue disease].
Yagi T; Yamagishi F; Mizutani F; Sasaki Y; Saitou M; Tada Y; Sakao S
Kekkaku; 1998 Sep; 73(9):557-62. PubMed ID: 9796208
[TBL] [Abstract][Full Text] [Related]
18. Comment on: a case of Raynaud's phenomenon in mixed connective tissue disease responding to Rituximab therapy response.
Dunkley L; Green M; Gough A
Rheumatology (Oxford); 2007 Oct; 46(10):1628-9. PubMed ID: 17766999
[No Abstract] [Full Text] [Related]
19. Pericardial effusions on anti-TNF therapy for rheumatoid arthritis--a drug side effect or uncontrolled systemic disease?
Edwards MH; Leak AM
Rheumatology (Oxford); 2009 Mar; 48(3):316-7. PubMed ID: 19106166
[No Abstract] [Full Text] [Related]
20. A case of difficult-to-treat autoimmune hepatitis successfully managed by TNF-alpha blockade.
Weiler-Normann C; Wiegard C; Schramm C; Lohse AW
Am J Gastroenterol; 2009 Nov; 104(11):2877-8. PubMed ID: 19888264
[No Abstract] [Full Text] [Related]
[Next] [New Search]
